Capitalizing on the Boom in Biotherapies
The term “biotherapies” broadly refers to medicinal products, including biopharmaceuticals, that are produced from biolo…
The term “biotherapies” broadly refers to medicinal products, including biopharmaceuticals, that are produced from biolo…
AB-1002 ist eine Gentherapie in der Entwicklung zur Behandlung von Erwachsenen mit nicht-ischämischer Kardiomyopathie un…
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in th…
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today anno…
company focusing on niche pharmaceutical products, are proud to announce a strategic collaboration aimed at advancing ph…
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidia…
NOMAD BIOSCIENCE GmbH, Munich, Germany (“NOMAD”) is pleased to announce that it has renewed and extended its development…
Der aktuelle Vogelgrippe-Ausbruch bei Säugetieren in Spanien zeigt das Potenzial des Grippe-Virus für eine Pandemie mit…
Genetisch modifizierte Masernviren sind vielversprechende Plattform für Forschung zu Masernviren und Entwicklung von Vek…
Efficient transfer of larger gene via ViGeneron’s proprietary technology platforms REVeRT and vgAAV ViGeneron advances i…